73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
ePoster Dienstag, 31.05.2022
Experimentelle Neuroonkologie II/Experimental Neurooncology II
Meeting Abstract
(P149)
[Volltext]
The role of onco-metabolite (R-2-hydroxyglutarate) in the IDH mutant glioblastoma microenvironment
Ravi VM, Behringer S, Joseph K, Beck J, Schnell O, Heiland DH[Volltext]
Meeting Abstract
(P150)
[Volltext]
Influence of the tumour microenvironment on the therapeutic response of residual tumour cells after GBM resection
Hellmold D, Kubelt C, Daunke T, Beckinger S, Janssen O, Hauck M, Schütt F, Adelung R, Sebens S, Synowitz M, Held-Feindt J[Volltext]
Meeting Abstract
(P151)
[Volltext]
A Multi-Omics approach to identify markers for glioblastoma recurrence
Schäfer A, Evers L, Benescu AC, Pojskic M, Nimsky C, Bartsch JW[Volltext]
Meeting Abstract
(P152)
[Volltext]
IL-17A, IL-22, IL-23 and CCL20 – influence on migration and invasion of rat glioblastoma cell lines using in vitro techniques and a rat organotypic brain slice co-culture (OBSC)
Falter J, Lohmeier A, Eberl P, Störr EM, Schmidt NO, Proescholdt M[Volltext]
Meeting Abstract
(P153)
[Volltext]
Inhibition of the protein tyrosine phosphatase PTP1B by the small molecule inhibitor Claramine inhibits the growth stimulation of EGF in glioblastoma cells
Dietel E, Gaunitz F, Meixensberger J[Volltext]
Meeting Abstract
(P154)
[Volltext]
Metabolic targeting of Carbonic Anhydrase 2 (CA-2) overcomes temozolomide resistance in GBM stem cells
Zhao K, Culmsee C, Nimsky C, Bartsch JW[Volltext]
Meeting Abstract
(P155)
[Volltext]
Nimodipine in combination with Vincristine – increases tumour cell susceptibility and protects normal tissue
Scheer M, Werner J, Strauss C, Scheller C, Leisz S[Volltext]
Meeting Abstract
(P156)
[Volltext]
Nimodipine pre-treatment protects auditory hair cells from cisplatin-induced cell death by upregulation of LMO4
Fritzsche S, Werner J, Strauss C, Scheller C, Leisz S[Volltext]
Meeting Abstract
(P157)
[Volltext]
Reproducibility of in vitro glioma research exemplified by the U-87 MG model
Sander T, Ghanawi J, Wilson E, Muhammad S, MacLeod M, Kahlert U[Volltext]
Meeting Abstract
(P158)
[Volltext]
Reversible blood-brain barrier opening utilising Tumour Treating Fields (TTFields) in a human 3D in vitro model
Salvador E, Köppl T, Keßler AF, Schönhärl S, Burek M, Tempel Brami C, Voloshin-Sela T, Giladi M, Ernestus RI, Löhr M, Förster C, Hagemann C[Volltext]
Meeting Abstract
(P159)
[Volltext]
TTFields empowers the anti-glioblastoma activity of CUSP9v3 in vitro
Cao Q, Dwucet A, Kast R, Hlavac M, Westhoff MA, Siegelin MD, Wirtz CR, Halatsch ME, Karpel-Massler G[Volltext]
Meeting Abstract
(P160)
[Volltext]
Expression of potential tumour suppressor LRIG1 is higher in low grade gliomas and in secondary glioblastomas compared to high grade gliomas and primary glioblastomas
Happe M, Goldbrunner R, Timmer M[Volltext]
